Brief: Jacobson Pharma Sees Increase Of Not Less Than 40% In Consol Profit Attributable For Year
01/06/2023 02:25
June 1 (Reuters) - Jacobson Pharma Corporation Ltd
2633.HK :
* JACOBSON PHARMA CORPORATION LTD SEES INCREASE OF NOT LESS
THAN
40% IN CONSOLIDATED PROFIT ATTRIBUTABLE FOR YEAR
* EXPECTED RESULT DUE TO GRADUAL EASING OF PANDEMIC-RELATED
RESTRICTIVE MEASURES IN MAINLAND CHINA, HONG KONG, AMONG OTHERS
Further company coverage: 2633.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jacobson Pharma
See all newsBrief: Jacobson Pharma Corp Says Chai Herbal To Buy 124,500 Shares Of Li Chung Shing Tong (Holdings)
Brief: Jacobson Pharma Corp's Unit Accepts Tender For Tai Po Factory Works At Hk$607.2 Million
Brief: Jacobson Pharma Corp Posts H1 Revenue Of HKD 766.6 Million
Brief: Jacobson Pharma Corporation Posts FY Net Income Attributable HKD 300.8 Million
Brief: Jacobson Pharma Corporation To Subscribe Shares In Tycoon Group